Haemonetics (HAE) News Today $79.91 +0.50 (+0.63%) As of 01/14/2025 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Haemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesHaemonetics Co. (NYSE:HAE - Get Free Report) has received an average recommendation of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given aJanuary 15 at 5:00 AM | marketbeat.comHaemonetics Completes Sale Of Whole Blood Assets To GVS For Approx. $67.8 MlnJanuary 14 at 3:15 PM | markets.businessinsider.comHaemonetics Completes Sale of Whole Blood Assets to GVS, S.p.AJanuary 14 at 6:13 AM | prnewswire.comHaemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025January 8, 2025 | prnewswire.comHaemonetics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | gurufocus.comHaemonetics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | prnewswire.comHaemonetics Co. (NYSE:HAE) Short Interest Up 7.4% in DecemberHaemonetics Co. (NYSE:HAE - Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 4,910,000 shares, a growth of 7.4% from the November 30th total of 4,570,000 shares. Currently, 9.9% of the company's shares are sold short. Based on an average daily volume of 592,200 shares, the short-interest ratio is currently 8.3 days.January 1, 2025 | marketbeat.comPrincipal Financial Group Inc. Has $12.48 Million Holdings in Haemonetics Co. (NYSE:HAE)Principal Financial Group Inc. decreased its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 19.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 155,259 shares of the medical instruments supplier's stock aftDecember 30, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Given Average Rating of "Moderate Buy" by BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nine research firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and oDecember 21, 2024 | marketbeat.comInvestors three-year returns in Haemonetics (NYSE:HAE) have not grown faster than the company's underlying earnings growthDecember 20, 2024 | finance.yahoo.comHaemonetics Co. (NYSE:HAE) Position Lifted by Geode Capital Management LLCGeode Capital Management LLC raised its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 1.8% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,193,927 shares of the medical instruments supplier's stock after purchasing an additional 21,547 shares during theDecember 20, 2024 | marketbeat.comKalVista: Potential First With Multiple Sebetralstat Regulatory Reviews In 2025December 18, 2024 | seekingalpha.comQ4 EPS Estimates for Haemonetics Boosted by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Zacks Research upped their Q4 2026 earnings per share (EPS) estimates for shares of Haemonetics in a report released on Monday, December 9th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earnings peDecember 12, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Purchased by Janus Henderson Group PLCJanus Henderson Group PLC raised its position in Haemonetics Co. (NYSE:HAE - Free Report) by 19.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 46,516 shares of the medical instruments supplier's stock aftDecember 12, 2024 | marketbeat.comZacks Research Forecasts Higher Earnings for HaemoneticsHaemonetics Co. (NYSE:HAE - Free Report) - Equities researchers at Zacks Research raised their FY2026 earnings per share estimates for shares of Haemonetics in a research note issued on Monday, December 9th. Zacks Research analyst R. Department now forecasts that the medical instruments supplierDecember 11, 2024 | marketbeat.comHaemonetics: Reassessing Its Growth Trajectory (Rating Downgrade)December 9, 2024 | seekingalpha.comBNP Paribas Financial Markets Grows Stock Position in Haemonetics Co. (NYSE:HAE)BNP Paribas Financial Markets grew its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 174.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,949 shares of the medical instruments supplier's stock aftDecember 9, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 9.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,201,565 shares of the medical instruments supplier's stDecember 8, 2024 | marketbeat.comFmr LLC Has $62.26 Million Stake in Haemonetics Co. (NYSE:HAE)Fmr LLC raised its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 206.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 774,529 shares of the medical instruments supplier's stock after purchasing aDecember 7, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Stock Holdings Cut by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company lessened its position in Haemonetics Co. (NYSE:HAE - Free Report) by 80.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 58,729 shares of the medical instruments supplier's stock after selliDecember 7, 2024 | marketbeat.comJP Morgan Initiates Coverage of Haemonetics (HAE) with Overweight RecommendationDecember 7, 2024 | msn.comHaemonetics started at overweight by J.P. MorganDecember 7, 2024 | msn.comHaemonetics (NYSE:HAE) Now Covered by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. assumed coverage on shares of Haemonetics in a research note on Friday. They issued an "overweight" rating and a $116.00 target price for the company.December 6, 2024 | marketbeat.comHaemonetics Corporation: Strategic Divestment and Innovation Drive Buy Rating with $125 TargetDecember 5, 2024 | markets.businessinsider.comHaemonetics’ Strategic Divestment to Boost Core Apheresis Focus and Long-term GrowthDecember 5, 2024 | markets.businessinsider.comHolocene Advisors LP Invests $5.42 Million in Haemonetics Co. (NYSE:HAE)Holocene Advisors LP purchased a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 67,419 shares of the medical instruments supplier's stock, valued at approxDecember 5, 2024 | marketbeat.com7,746 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Paloma Partners Management CoPaloma Partners Management Co bought a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,746 shares of the medical instruments supplier's stock,December 4, 2024 | marketbeat.comAtom Investors LP Invests $1.57 Million in Haemonetics Co. (NYSE:HAE)Atom Investors LP purchased a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 19,545 shares of the medical instruments supplier's stock, valued atDecember 3, 2024 | marketbeat.comBridgewater Associates LP Sells 35,747 Shares of Haemonetics Co. (NYSE:HAE)Bridgewater Associates LP lowered its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 82.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,826 shares of the medical instruments supplier's stDecember 3, 2024 | marketbeat.comHaemonetics To Sell Its Whole Blood Assets To GVS - Quick FactsDecember 3, 2024 | markets.businessinsider.comHaemonetics Announces Sale of Whole Blood Assets to GVS, S.p.ADecember 3, 2024 | gurufocus.comHaemonetics Announces Sale of Whole Blood Assets to GVS, S.p.ADecember 3, 2024 | prnewswire.comZacks Research Decreases Earnings Estimates for HaemoneticsHaemonetics Co. (NYSE:HAE - Free Report) - Investment analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Haemonetics in a report issued on Wednesday, November 27th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earningsDecember 2, 2024 | marketbeat.comIsthmus Partners LLC Sells 8,326 Shares of Haemonetics Co. (NYSE:HAE)Isthmus Partners LLC reduced its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 17.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 39,770 shares of the medicalNovember 29, 2024 | marketbeat.comCitigroup Inc. Has $15.57 Million Stake in Haemonetics Co. (NYSE:HAE)Citigroup Inc. trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 96.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,658 shares of the medical instruments supplier's stock after selling 5,678,717November 28, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Acquired by Loomis Sayles & Co. L PLoomis Sayles & Co. L P increased its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 8.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 163,856 shares of the medical instruments supplierNovember 27, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight analysts that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, five have issued a buy recommendatioNovember 26, 2024 | marketbeat.comIntech Investment Management LLC Acquires 8,626 Shares of Haemonetics Co. (NYSE:HAE)Intech Investment Management LLC grew its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 62.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,329 shares of the medical instrumNovember 26, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by Eagle Asset Management Inc.Eagle Asset Management Inc. reduced its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 54.1% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 100,565 shares of the medical instruments supplier's stock after selling 118,636 shares during the peNovember 25, 2024 | marketbeat.comWestfield Capital Management Co. LP Has $66.21 Million Position in Haemonetics Co. (NYSE:HAE)Westfield Capital Management Co. LP raised its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 10.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 823,663 shares of the medical instruments supplier's sNovember 24, 2024 | marketbeat.comAdvancements and market trends in arteriotomy closure devicesNovember 22, 2024 | yahoo.comHaemonetics Co. (NYSE:HAE) Shares Bought by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 439.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 220,453 shares of the medical instruments supplier's stock after purchasing an additionalNovember 21, 2024 | marketbeat.comGlobal Alpha Capital Management Ltd. Makes New Investment in Haemonetics Co. (NYSE:HAE)Global Alpha Capital Management Ltd. purchased a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,025 shares of the medicaNovember 20, 2024 | marketbeat.comThrivent Financial for Lutherans Has $88.43 Million Position in Haemonetics Co. (NYSE:HAE)Thrivent Financial for Lutherans boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 29.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,100,183 shares of the medical instruments supplNovember 18, 2024 | marketbeat.comPrincipal Financial Group Inc. Decreases Stake in Haemonetics Co. (NYSE:HAE)Principal Financial Group Inc. lessened its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 19.4% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 155,259 shares of the medical instruments supplier's stock afterNovember 17, 2024 | marketbeat.comStrategic Investment and Growth Potential Drive Buy Rating for HaemoneticsNovember 16, 2024 | markets.businessinsider.comMizuho Markets Americas LLC Sells 15,116 Shares of Haemonetics Co. (NYSE:HAE)Mizuho Markets Americas LLC trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 4.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 348,478 shares of the medical instruments supplier's stock after sellingNovember 16, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $112.00 price objective on shares of Haemonetics in a research report on Friday.November 15, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) is Royce & Associates LP's 6th Largest PositionRoyce & Associates LP lifted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 2.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,210,546 shares of the medical instruments supplier's stock afterNovember 15, 2024 | marketbeat.comAigen Investment Management LP Makes New Investment in Haemonetics Co. (NYSE:HAE)Aigen Investment Management LP acquired a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,959 shares of the medical instruments supplier'November 15, 2024 | marketbeat.com Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼0.330.78▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼35▲HAE Articles Average Week Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Align Technology News Merit Medical Systems News ICU Medical News DENTSPLY SIRONA News QuidelOrtho News Neogen News STAAR Surgical News Cerus News OraSure Technologies News Anika Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
